RenovoRx Historical Financial Ratios
| RNXT Stock | USD 1.21 0.08 6.20% |
RenovoRx is promptly reporting on over 81 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 0.0, Stock Based Compensation To Revenue of 0.0, Capex To Depreciation of 1.34 or Ev To Sales of 0.0 will help investors to properly organize and evaluate RenovoRx financial condition quickly.
RenovoRx |
About RenovoRx Financial Ratios Analysis
RenovoRxFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate RenovoRx investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on RenovoRx financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across RenovoRx history.
RenovoRx Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most ratios from RenovoRx's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's ROIC is comparatively stable compared to the past year. ROE is likely to gain to 3.58 in 2024, whereas Free Cash Flow Yield is likely to drop (0.46) in 2024.
| 2022 | 2023 | 2024 (projected) | Current Ratio | 6.59 | 1.25 | 1.19 | Net Debt To EBITDA | 0.65 | 0.1 | 0.0978 |
RenovoRx fundamentals Correlations
Click cells to compare fundamentals
RenovoRx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.